Tumor Type |
miRNA up-regulated |
miRNA down-regulated |
Samples Setting |
Methods |
References |
Lymphoma CNS |
-21, -19b, -92a |
|
CNS DLBCL vs Inflammatory CNS disorders |
qRT-PCR |
[21] |
|
-21, -19b |
-16, -127 |
CNS DLBCL vs extranodal DLBCL |
qRT-PCR and ISH |
[64] |
|
-9, -20b, -155, -340, -17-5p, -148a |
-199a, -214, -432, -193b, -145 |
CNS DLBCL vs LN DLBCL |
qRT-PCR |
[61] |
Meningioma |
-335, -98, -181a, -19b, let7d, let7g, -100, -125a, -103, -370, -106b, -106a, -125b, let7b, -26a, -23b, -29a |
-200a, -373*, -575 |
Meningioma vs Normal Brain |
Microarray and qRT-PCR |
[45] |
|
-145, let-7d |
Meningioma vs Normal Brain |
qRT-PCR |
[36] |
|
-145 |
G2-G3 vs G1 |
|
[36] |
-335 |
|
Meningioma vs Normal Brain |
qRT-PCR |
[46] |
-17-5p, -22-3p, -24-3p, -26b-5p, -27a-3p, -27b-3p, -96-5p, -146a-5p, -155-5p, -186-5p, -190a, -199a |
-29c-3p, -219-5p |
Meningioma vs Normal Brain |
qRT-PCR |
[54] |
-96-5p, -190a |
|
Patients with Recurrence vs Without |
|
[54] |
-29c-3p, -219-5p |
|
Patients Without Recurrence vs With Recurrence |
|
[54] |
Pituitary Adenomas |
-26a, -149 |
-21, -141, -144 |
Pituitary Adenomas vs normal |
Microarray |
[22] |
-320 |
-34b, -326, -374b, -432, -548c-3p, -570, -603, -33 |
GH-adenomas vs normal |
Microarray |
[27] |
-183, -193a-5p, -222, -516b, -524-5p, -601, -629, -99b |
-124, -32, -574-5p, -744, -96 |
Macro- vs Micro-adenomas |
Microarray |
[41] |
-135a, -140-5p, -582-3p, -582-5p, -938, -124*, -515-5p, -872 |
-198, -299-5p, -497*, -548c-3p, -622 |
Pituitary Adenomas vs normal |
qRT-PCR |
[23] |
-378, -516-3p, -151-3p, -224, -618, -455-3p, -29b |
-509-3-5p, -508-5p, -452, -330-5p, -200a, -503, -424, -449a, -199-5p |
Pituitary Adenomas vs normal |
qRT-PCR |
[51] |
-217, -216a, -215, -502, -338, -10b, -96, -202, -501, -18a, -450a, -329 |
|
Non-functioning pituitary adenoma |
|
[51] |
-1, -760, -196b, -188-5p, -146b-3p |
|
GH-adenoma |
|
[51] |
-205, -132*, -523 |
|
PRL-adenoma |
|
[51] |